EU green light to IntraBio’s AQNEURSA for rare neurological disease Niemann-Pick Type C
The approval is grounded in data from a Phase III randomized, double-blind, placebo-controlled, crossover study in NPC patients
The approval is grounded in data from a Phase III randomized, double-blind, placebo-controlled, crossover study in NPC patients
This license is a key regulatory milestone in advancing Hester's prevention-led poultry healthcare portfolio
Granules India has reported total income of Rs. 1,384.29 crore during the period ended December 31, 2025
This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
Company to launch product after the expiry of semaglutide patent in India
Cipla has reported total income of Rs. 7,280.82 crore during the period ended December 31, 2025
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
Gastrointestinal conditions affect millions across the UK, yet research in the field has often been fragmented, slow, or under-resourced
The partnership initially will focus on cardiovascular and kidney diseases
Subscribe To Our Newsletter & Stay Updated